Seres Therapeutics, Inc. (NASDAQ:MCRB) Q4 2022 Earnings Call Transcript

Operator: Thank you for holding, and welcome everyone, to the Seres Therapeutics Fourth Quarter 2022 Conference Call. . Thank you. I will now turn the call over to Dr.

Keep Reading →